Phase 3 Acute Pain Clinical Trials
6 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–6 of 6 trials
Recruiting
Phase 3
Fentanyl or Esketamine for Traumatic PAIN (FORE-PAIN) Trial
AnalgesiaEsketamineFentanyl+2 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)608 enrolled1 locationNCT06051227
Recruiting
Phase 3
Intravenous Ketorolac Vs. Morphine In Children With Acute Abdominal Pain
AppendicitisChild, OnlyEmergencies+3 more
University of Calgary495 enrolled1 locationNCT06160778
Completed
Phase 2Phase 3
Comparing Oral and Sublingual Ketamine Lozenges as Rescue Analgesics in Adults with Acute Pain
Acute Pain
University of Western Australia30 enrolled1 locationACTRN12621000240842
Terminated
Phase 3Phase 4
Is ketamine a useful addition for the management of acute pain in patients where opiates alone have failed to provide adequate analgesia?
Difficult to control acute pain
Bundaberg Base Hospital65 enrolled1 locationACTRN12615001151527
Completed
Phase 3Phase 4
Optimising Management of acute pain in Opioid Substitution Therapy patients: A pilot laboratory randomised study
Acute pain in opioid dependence
Sydney Local Health District - Royal Prince Alfred Hospital36 enrolled1 locationACTRN12612000288820
Terminated
Phase 3
Gabapentin for taxane associated acute pain syndrome - randomised, placebo-controlled, crossover trial. The TAPS Trial
Taxane associated acute pain syndrome
Sunshine Coast Cancer Centre, Nambour General Hospital126 enrolled1 locationACTRN12611000666921